” The Burden of Salmonella in Poultry: Implications for Health, Productivity, and Biosecurity “

Salmonella is a leading cause of foodborne illness globally, with non-typhoidal serotypes like S. Enteritidis and S. Typhimurium responsible for the majority of gastroenteritis cases. In India, though national surveillance data is limited, reports under the Integrated Disease Surveillance Programme (IDSP) show hundreds of foodborne outbreaks annually, with thousands affected. Vulnerable groups such as infants and immune compromised individuals are particularly at risk, as even low doses of Salmonella can trigger severe illness. South Asia reports an estimated 2.2 cases of invasive non-typhoidal Salmonella per 100,000 people annually, with a high fatality rate. Poultry—especially chicken meat and eggs—remains a primary reservoir, with multiple studies indicating widespread contamination and rising antimicrobial resistance, posing significant public health risks.

With increasing demand for poultry and growing concerns over antibiotic resistance, India faces the challenge of balancing production efficiency with food safety. Regulatory moves to restrict antibiotic use, combined with consumer preference for antibiotic-free meat, are pushing the industry towards alternative control strategies. Preharvest measures like biosecurity, improved farm hygiene, and feed additives, along with postharvest controls such as HACCP implementation, are being emphasized. Vaccination has become a core preventive tool; however, the need persists for more robust vaccines offering cross-protection against diverse and emerging serotypes. This review highlights the current understanding of Salmonella in poultry and explores sustainable control approaches suitable for the Indian context.

Transmission:

Salmonella primarily spreads through the faeces of infected chicks, contaminated feed, water, and litter. Human activities, such as farm visits without proper biosecurity and movement between chicken houses, also contribute to its spread. Transmission occurs via direct contact with infected birds or indirectly through contaminated environments. Vertical transmission, particularly through infected eggs, is key in sustaining outbreaks, as asymptomatic carriers can pass the bacteria to offspring for up to 14 weeks. These bacteria can survive in the environment for months under favourable conditions, though sunlight and high temperatures reduce their persistence. Wild birds, mammals, and insects, especially red mites, can act as vectors, complicating control efforts.

Fig.1: Transmission of Salmonella.

Pathogenesis:

             Salmonella pathogenesis starts when bacteria are ingested, surviving the stomach’s acidity to invade the intestinal mucosa using virulence factors like plasmids, toxins, fimbriae and flagella. They infect non-phagocytic cells and macrophages, triggering inflammation and evading the immune system. The bacteria spread via the bloodstream to organs like the liver, spleen and kidneys causing symptoms such as diarrhoea, loss of appetite and depression, leading to high mortality, especially in young chicks. Salmonella can be transmitted both vertically and horizontally. It induces inflammation, macrophage apoptosis, and can cause severe haemolytic anaemia, leading to rapid death. The incubation period is typically 4 to 6 days.

Clinical signs:

Pullorum disease mainly affects young birds particularly chicks under 3-4 weeks old, with peak mortality at 2-3 weeks. Infected embryos may die in the egg and recently hatched chicks often exhibit signs of acute septicaemia such as depression, weakness, loss of appetite, drooping wings, huddling, laboured breathing, dehydration, and ruffled feathers. White, viscous diarrhoea and faecal pasting around the vent are common. Older chicks may experience a less acute disease course, sometimes developing arthritis or blindness. Survivors may be underweight, poorly feathered and less productive as adults. Infections in birds older than 4 weeks are usually asymptomatic but can result in decreased egg production and fertility. Fowl typhoid affects birds of all ages with symptoms like depression, appetite loss, weight loss, dehydration, ruffled feathers, yellowish diarrhoea and respiratory distress. Older birds may experience decreased egg production, fertility, and hatchability leading to anaemia with pale, shrunken combs and wattles. Atypical outbreaks, such as one in quail characterized by decreased egg laying and high mortality without clear clinical signs can also occur.

Diagnosis:

Lesions may be highly suggestive; however, diagnosis should be confirmed by isolation, identification, and serotyping of S Pullorum. Infections in mature birds can be identified by serological tests, followed by necropsy evaluation complemented by microbiological culture and typing for confirmation.

Official testing recommendations for flocks in the US are outlined in the National Poultry Improvement Plan (NPIP). The NPIP lists approved rapid assays for Salmonella. These include, for example, PCR assay and lateral flow immunoassays. Some assays are for the general detection of all Salmonella spp. Further typing is required after these general detection assays. Other NPIP-approved rapid assays are specific for Salmonella enterica serotype enteritidis like plasmid profiling and ribotyping, aid in accurate identification and differentiation.

Postmortem lesions:

The liver is yellowish in colour with haemorrhagic streaks. In chronic cases the ovary consists of pedunculate and misshapen ovules. The most obvious lesion includes enlarged and congested liver, which becomes dark red or brown (bile-stained liver) after exposure to the atmosphere. There may be multiple necrotic areas throughout the liver. There is congestion and necrosis of the liver and spleen with catarrhal enteritis.

Fig. 2 Granulomatous hepatitis, liver, chicken

Antimicrobial Resistance:

Antimicrobial resistance is a growing global challenge, worsened by insufficient assessments of Salmonella resistance and lack of regulation. The easy access to antimicrobials without prescriptions, along with incomplete treatments, exacerbates the problem. In poultry farming, the overuse of antibiotics has led to the development of resistant strains, including those producing extended spectrum beta-lactamases (ESBLs), posing a serious threat to both public health and the poultry industry (Parvej et al., 2016). Resistance mechanisms include bacterial target modifications, changes in cell membrane permeability, and efflux pumps. Misuse of antibiotics has resulted in the rise of multidrug-resistant Salmonella strains, making treatment more difficult and highlighting the need for more careful antibiotic use (Farhat et al., 2023).

Prevention and control:

Preventing and controlling salmonellosis on poultry farms is essential. Key strategies include removing infected birds, keeping healthy and sick birds separate and using testing methods like tube-agglutination to screen flocks. Strong biosecurity measures, such as strict hygiene, controlled farm access, and proper management of litter, feed, and water, help reduce disease spread. Without these measures, fowl typhoid poses a significant economic threat, highlighting the need for organized control programs with accurate testing and prompt action.

Vaccination plays a crucial role in preventing and controlling salmonellosis on poultry farms. Effective vaccines can help reduce infection rates of fowl typhoidand salmonella enteritidis providing long-term protection for flocks. In addition to vaccination, strategies like early identification and removal of infected birds, routine testing, and strict biosecurity measures (e.g., hygiene, controlled farm access) are essential for minimizing disease spread. Combining vaccination with proper management of litter, feed, and water enhances flock health and reduces the economic impact of fowl typhoid, making it a key component of any comprehensive disease control program.

Stallen South Asia Pvt. Ltd. is offering a unique live vaccine BIO-VAC SGP 695, against fowl typhoid and salmonella Enteritidis.

Key features of BIO-VAC SGP 695

  • BIO-VAC SGP 695 contains the live attenuated strain SGP 695 AV of Salmonella gallinarum/pullorum that induces a strong active immunity in vaccinated pullets, against fowl typhoid, reducing mortality, clinical signs, pathological lesions, losses in eggs production and against Salmonella enteritidis infection, reducing the colonisation of internal organs and ovary.
  • In drinking water administration.
  • Stable attenuated and total apathogenicity of the vaccine strain.
  • Reduction of vaccination procedure costs.

Why choose BIO-VAC SGP 695 than SG 9R salmonella vaccine?

 BIO- VAC SGP 695SG  9R vaccine
Strain695 AV (Live attenuated)9R (Rough strain with possible reversion)
CharacteristicsDoes not revert to virulencePossible reversion to virulence
Targeted InfectionsSalmonella gallinarum, Salmonella pullorum, Salmonella EnteritidisPrimarily Salmonella gallinarum (Fowl Typhoid)
AdministrationOral (via drinking water)Subcutaneous injection
Vaccination ProgramInitial dose at 6-8 weeks, second at 16-18 weeks. Early dose if early infection history.Initial dose at 6 weeks, revaccination every 12 weeks for layers.
EffectivenessBroad protection including Salmonella EnteritidisFocused on protection against Salmonella gallinarum

Fig 3: ELISA report of BIO-VAC SGP  695 and SG 9R vaccine

Dr. Kishor Gedam

Product Manager- Therapeutics

Stallen South Asia Pvt. Ltd

Dr. Sanjay Singhal

Chief Operating Officer Stallen South Asia Pvt. Ltd

References

  1. Jajere, S.M., 2019. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Vet. World, 12: 2231-0916.
  2. Kebede, D., Z. Tekle, A. Gezahegne, G. Abdisa, R. Mulatu, A. Wondimu and A. Ayesheshum, 2019. Review on Salmonella Gallinarum-Pullorum. British Journal of Poultry Sciences, 8(1): 10-16.
  3. Davison, S., 2019. Pullorum Disease in Poultry, Laboratory of Avian Medicine and Pathology, School of Veterinary Medicine, University of Pennsylvania, pp: 1-20.
  4. Parvej, M.S., K.H. Nazir, M.B. Rahman, M. Jahan,M.F. Khan and M. Rahman, 2016. Prevalence and characterization of multi-drug resistant Enterica serovar gallinarum biovar Pullorum and gallinarum from chicken. Vet. World, 9(1): 65-70.
  5. Farhat, M., Khayi, S., Berrada, J., Mouahid, M., Ameur, N., El-Adawy, H., & Fellahi, S. (2023). Salmonella enterica Serovar Gallinarum Biovars Pullorum and Gallinarum in Poultry: Review of Pathogenesis, Antibiotic Resistance, Diagnosis and Control in the Genomic Era. Antibiotics13(1), 23.

Stallen Technical Meet—November 2025, on Poultry Health & Immunization Held in Midnapore, West Bengal

Stallen South Asia Pvt. Ltd. successfully organized a high-impact Technical Meeting for poultry farmers in Midnapore, West Bengal, on 18th November 2025. The event saw the participation of over 30 progressive layer farmers, making it a meaningful platform for scientific discussion, disease awareness, and interaction with experts. The program began with a warm welcome by Mr. Biplab Kumar Deb, Regional Manager, who emphasized the company’s commitment to strengthening poultry health management in the region through regular technical interventions and farmer engagement.

This was followed by an insightful Company Introduction delivered by Dr. Sanjay Singhal, Chief Commercial Officer. He highlighted the growth of Stallen South Asia Pvt. Ltd., its role in bringing high-quality poultry health solutions to India, and its long-standing collaboration with FATRO, Italy, a global leader in vaccine research and development. Dr. Singhal also discussed the company’s vision of delivering innovative and reliable immunization tools to Indian farmers, backed by international expertise.

The highlight of the event was an in-depth Technical Seminar by Dr. Sushil Kumar Dhariwal, a respected poultry consultant with over 17 years of experience in breeder and layer management. His session, titled “Combating RD, IB, Marek’s and Coryza: Understanding Disease Mechanisms and Immunization Strategies,” focused on the evolving challenges of respiratory and immunosuppressive diseases in layer flocks. Dr. Dhariwal explained disease mechanisms, practical vaccination approaches, and flock-level management strategies, providing farmers with actionable insights for improving immunity and reducing disease pressure.

Following the seminar, Dr. Kishor Gedam, Product Manager, delivered a comprehensive Product Presentation, highlighting Stallen South Asia’s range of poultry vaccines developed in collaboration with FATRO. He discussed the science behind key vaccines used against diseases such as RD, IB, Marek’s Disease and Infectious Coryza, along with field performance, strain selection, and best practices for vaccination scheduling. His presentation helped farmers understand how effective immunization programs can significantly enhance flock performance and reduce economic losses.

The event concluded with a heartfelt vote of thanks from Team Stallen South Asia, followed by a networking dinner that encouraged open conversation between farmers and technical experts. The interactive discussions reflected the strong interest and enthusiasm among farmers to adopt improved disease-prevention strategies.

With active participation and highly positive feedback from attendees, the event reaffirmed Stallen South Asia Pvt. Ltd.’s commitment to empowering poultry farmers with global-quality vaccines, scientific knowledge and on-ground technical support.

Stallen South Asia Hosts Technical Seminar on “Comprehensive Flock Protection: Addressing Mycoplasmosis, Infectious Bronchitis & Salmonellosis” in Pune

In continuation of its commitment to strengthen scientific knowledge and promote advanced disease control strategies in the poultry sector, Stallen South Asia Pvt. Ltd. organized a highly informative technical seminar in Pune, themed “Comprehensive Flock Protection: Addressing Mycoplasmosis, Infectious Bronchitis & Salmonellosis.”

The event witnessed the participation of over 80 progressive poultry farmers, consultants, and technical experts, who gathered to explore emerging disease trends, modern vaccine technologies, and integrated flock protection programs aimed at improving productivity and profitability.

The seminar opened with a warm welcome by Dr. Sanjay Singhal, Chief Operating Officer, Stallen South Asia Pvt. Ltd., who shared the inspiring journey of Stallen — from its modest beginnings in the late 1990s as a pharmaceutical company to its current evolution into a biotechnology-focused organization. Dr. Singhal emphasized how Stallen has constantly adapted to the changing needs of the poultry industry, shifting from conventional drugs to next-generation biologicals and vaccines that align with global trends in responsible poultry production. He also spoke about the company’s product range, collaborations, and upcoming innovations, reaffirming Stallen’s vision to offer science-driven solutions that ensure healthier flocks and sustainable farming.

The technical keynote address was delivered by Dr. Jayaraman K, a veteran poultry health expert with more than three decades of experience. In his session, Dr. Jayaraman provided an in-depth overview of the disease triad — Mycoplasmosis, Infectious Bronchitis, and Salmonellosis — explaining how these infections interact, compromise respiratory health, and affect egg production, hatchability, and overall flock performance. He discussed diagnostic approaches, field management practices, and the role of vaccination in breaking the infection cycle. His presentation was both insightful and practical, blending scientific clarity with field relevance, which kept the audience thoroughly engaged. The interactive Q&A session that followed helped participants gain clarity on key aspects of disease prevention and control.

The final session was conducted by Dr. Kishor Gedam, Product Manager, Stallen South Asia Pvt. Ltd., who presented Stallen’s comprehensive vaccine portfolio imported directly from FATRO, Italy. He elaborated on flagship products such as MYC-VAC — a Mycoplasma gallisepticum killed vaccine, MS-VAC — a Mycoplasma synoviae killed vaccine, and IB-OLVAC, a killed vaccine offering protection against Infectious Bronchitis and Newcastle Disease. Dr. Gedam also introduced BIOVAC SGP695, an innovative patented live vaccine for Salmonella gallinarum/pullorum, and enteritidis infections, which is notably the first water-administered Salmonella vaccine available in the Indian market. Together, these products represent Stallen’s holistic approach to flock protection — offering reliable, science-backed, and field-tested vaccination options to Indian poultry producers.

The event concluded with a heartfelt vote of thanks by Mr. Macchindra Shinde, Regional Sales Manager (West), who appreciated the enthusiastic participation of the attendees and the valuable insights shared by the speakers. A networking dinner followed, allowing farmers, consultants, and experts to interact informally and exchange ideas for improving poultry health and productivity.

With this successful seminar, Stallen South Asia once again reaffirmed its dedication to knowledge sharing, innovation, and farmer partnership. The company continues to take confident strides toward building a healthier, more productive poultry industry — one that thrives on science, sustainability, and shared success.

WhatsApp Bot